Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Envoy Medical (COCH)
NASDAQ:COCH
Envoy Medical (COCH) Stock Price & Analysis
34 Followers
COCH Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.75 - $11.72
Previous Close$5.17
Volume59.50K
Average Volume (3M)445.25K
Market Cap
$101.33M
Enterprise Value$93.89M
Total Cash (Recent Filing)$7.44M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-28.2
Beta0.42
Next Earnings
Apr 02, 2024EPS Estimate
-$0.23Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.18
Shares Outstanding19,599,982
10 Day Avg. Volume64,383
30 Day Avg. Volume445,255
Standard Deviation0.57
R-Squared0.06
Alpha0.04
Financial Highlights & Ratios
Price to Book (P/B)15.59
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-7.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.17K
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda40.71
Forecast
1Y Price Target
$6.00Price Target Upside15.83% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Envoy Medical News
Bulls Say, Bears Say
Bulls Say
Market PotentialEnvoy Medical is developing the first fully implantable cochlear implant for severe to profound hearing loss, addressing a massive underpenetrated market.
Product AdvantagesAnalyst believes Envoy Medical's superior product offers an advantage in the established market, indicating a positive outlook for the company.
Regulatory ApprovalExpected regulatory catalysts, such as FDA approval, could drive investor interest and support a higher stock valuation for Envoy Medical.
Bears Say
Capital RequirementsThe current balance sheet likely necessitates additional capital in the near term.
Financial PositionEnvoy Medical's current financial position may require additional capital in the near term, presenting potential dilution risk for current shareholders.
Regulatory ApprovalThe potential for future FDA approval and market penetration presents an attractive buying opportunity.
---
Ownership Overview
63.88% Insiders
8.93% Mutual Funds
8.01% Other Institutional Investors
19.17% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
COCH FAQ
What was Envoy Medical’s price range in the past 12 months?
Envoy Medical lowest stock price was $0.75 and its highest was $11.72 in the past 12 months.
What is Envoy Medical’s market cap?
Currently, no data Available
When is Envoy Medical’s upcoming earnings report date?
Envoy Medical’s upcoming earnings report date is Apr 02, 2024 which is 26 days ago.
How were Envoy Medical’s earnings last quarter?
Envoy Medical released its earnings results on Nov 20, 2023. The company reported $0.13 earnings per share for the quarter, the consensus estimate of $0.13 by $0.
Is Envoy Medical overvalued?
According to Wall Street analysts Envoy Medical’s price is currently Undervalued.
Does Envoy Medical pay dividends?
Envoy Medical does not currently pay dividends.
What is Envoy Medical’s EPS estimate?
Envoy Medical’s EPS estimate is -$0.23.
How many shares outstanding does Envoy Medical have?
Envoy Medical has 19,599,981 shares outstanding.
What happened to Envoy Medical’s price movement after its last earnings report?
Envoy Medical reported an EPS of $0.13 in its last earnings report, expectations of $0.13. Following the earnings report the stock price went up 1.818%.
Which hedge fund is a major shareholder of Envoy Medical?
Among the largest hedge funds holding Envoy Medical’s share is Moore Capital Management LP. It holds Envoy Medical’s shares valued at N/A.
---
Envoy Medical Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$6.00 (15.83% Upside)
$6.00 (15.83% Upside)
Blogger Sentiment
Bullish
COCH Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 297.6K Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-49.50%
12-Months-Change
Fundamentals
Return on Equity
-1.82%
Trailing 12-Months
Asset Growth
-98.23%
Trailing 12-Months
Company Description
Envoy Medical
Anzu Special Acquisition Corp I is a blank check company.
---
COCH Stock 12 Months Forecast
Average Price Target
$6.00
▲(15.83% Upside)
Technical Analysis
Best Analysts Covering COCH
1 Year
1 Year Success Rate
2/3 ratings generated profit
1 Year Average Return
+66.20%
reiterated a buy rating 25 days ago
Copying Frank Takkinen's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +66.20% per trade.
---